nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Nicotine—ulcerative colitis	0.239	0.489	CbGbCtD
Ezogabine—CYP2A6—Prednisolone—ulcerative colitis	0.158	0.322	CbGbCtD
Ezogabine—CYP2A6—Dexamethasone—ulcerative colitis	0.0929	0.19	CbGbCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC39A11—ulcerative colitis	0.00159	0.044	CbGpPWpGaD
Ezogabine—UGT1A1—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.00149	0.0413	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—SLC39A11—ulcerative colitis	0.00132	0.0366	CbGpPWpGaD
Ezogabine—Malaise—Azathioprine—ulcerative colitis	0.00122	0.00258	CcSEcCtD
Ezogabine—Shock—Budesonide—ulcerative colitis	0.00122	0.00258	CcSEcCtD
Ezogabine—Psychotic disorder—Betamethasone—ulcerative colitis	0.00122	0.00257	CcSEcCtD
Ezogabine—Psychotic disorder—Dexamethasone—ulcerative colitis	0.00122	0.00257	CcSEcCtD
Ezogabine—Nervous system disorder—Budesonide—ulcerative colitis	0.00122	0.00257	CcSEcCtD
Ezogabine—Leukopenia—Azathioprine—ulcerative colitis	0.00122	0.00257	CcSEcCtD
Ezogabine—Hyperhidrosis—Budesonide—ulcerative colitis	0.0012	0.00253	CcSEcCtD
Ezogabine—Dizziness—Nicotine—ulcerative colitis	0.00119	0.00252	CcSEcCtD
Ezogabine—Muscle spasms—Mesalazine—ulcerative colitis	0.00119	0.00251	CcSEcCtD
Ezogabine—Influenza—Triamcinolone—ulcerative colitis	0.00119	0.00251	CcSEcCtD
Ezogabine—Weight increased—Prednisolone—ulcerative colitis	0.00118	0.00248	CcSEcCtD
Ezogabine—Rash—Mercaptopurine—ulcerative colitis	0.00117	0.00248	CcSEcCtD
Ezogabine—Dermatitis—Mercaptopurine—ulcerative colitis	0.00117	0.00247	CcSEcCtD
Ezogabine—Vision blurred—Mesalazine—ulcerative colitis	0.00117	0.00246	CcSEcCtD
Ezogabine—KCNQ3—L1CAM interactions—LAMB1—ulcerative colitis	0.00117	0.0323	CbGpPWpGaD
Ezogabine—KCNQ2—L1CAM interactions—LAMB1—ulcerative colitis	0.00117	0.0323	CbGpPWpGaD
Ezogabine—Tremor—Mesalazine—ulcerative colitis	0.00116	0.00245	CcSEcCtD
Ezogabine—Increased appetite—Prednisone—ulcerative colitis	0.00116	0.00244	CcSEcCtD
Ezogabine—Amnesia—Prednisone—ulcerative colitis	0.00116	0.00244	CcSEcCtD
Ezogabine—Weight increased—Hydrocortisone—ulcerative colitis	0.00115	0.00242	CcSEcCtD
Ezogabine—Ill-defined disorder—Mesalazine—ulcerative colitis	0.00115	0.00242	CcSEcCtD
Ezogabine—Discomfort—Azathioprine—ulcerative colitis	0.00114	0.00241	CcSEcCtD
Ezogabine—Rash—Nicotine—ulcerative colitis	0.00114	0.0024	CcSEcCtD
Ezogabine—Dermatitis—Nicotine—ulcerative colitis	0.00114	0.0024	CcSEcCtD
Ezogabine—Infestation NOS—Hydrocortisone—ulcerative colitis	0.00113	0.00238	CcSEcCtD
Ezogabine—Infestation—Hydrocortisone—ulcerative colitis	0.00113	0.00238	CcSEcCtD
Ezogabine—Malaise—Mesalazine—ulcerative colitis	0.00112	0.00235	CcSEcCtD
Ezogabine—Paraesthesia—Budesonide—ulcerative colitis	0.00111	0.00235	CcSEcCtD
Ezogabine—Vertigo—Mesalazine—ulcerative colitis	0.00111	0.00235	CcSEcCtD
Ezogabine—Syncope—Mesalazine—ulcerative colitis	0.00111	0.00234	CcSEcCtD
Ezogabine—Leukopenia—Mesalazine—ulcerative colitis	0.00111	0.00234	CcSEcCtD
Ezogabine—Dyspnoea—Budesonide—ulcerative colitis	0.00111	0.00234	CcSEcCtD
Ezogabine—Nausea—Mercaptopurine—ulcerative colitis	0.0011	0.00233	CcSEcCtD
Ezogabine—Somnolence—Budesonide—ulcerative colitis	0.0011	0.00233	CcSEcCtD
Ezogabine—Infection—Azathioprine—ulcerative colitis	0.0011	0.00232	CcSEcCtD
Ezogabine—Dyspepsia—Budesonide—ulcerative colitis	0.00109	0.00231	CcSEcCtD
Ezogabine—Loss of consciousness—Mesalazine—ulcerative colitis	0.00109	0.00229	CcSEcCtD
Ezogabine—Osteoarthritis—Prednisone—ulcerative colitis	0.00109	0.00229	CcSEcCtD
Ezogabine—Thrombocytopenia—Azathioprine—ulcerative colitis	0.00109	0.00229	CcSEcCtD
Ezogabine—Weight increased—Triamcinolone—ulcerative colitis	0.00108	0.00228	CcSEcCtD
Ezogabine—Weight increased—Methylprednisolone—ulcerative colitis	0.00108	0.00228	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00107	0.00226	CcSEcCtD
Ezogabine—Nausea—Nicotine—ulcerative colitis	0.00107	0.00226	CcSEcCtD
Ezogabine—Fatigue—Budesonide—ulcerative colitis	0.00107	0.00226	CcSEcCtD
Ezogabine—Constipation—Budesonide—ulcerative colitis	0.00106	0.00224	CcSEcCtD
Ezogabine—Psychotic disorder—Prednisone—ulcerative colitis	0.00106	0.00224	CcSEcCtD
Ezogabine—Infestation—Methylprednisolone—ulcerative colitis	0.00106	0.00223	CcSEcCtD
Ezogabine—Infestation NOS—Methylprednisolone—ulcerative colitis	0.00106	0.00223	CcSEcCtD
Ezogabine—Anxiety—Mesalazine—ulcerative colitis	0.00105	0.00221	CcSEcCtD
Ezogabine—Discomfort—Mesalazine—ulcerative colitis	0.00104	0.0022	CcSEcCtD
Ezogabine—Dry mouth—Mesalazine—ulcerative colitis	0.00103	0.00217	CcSEcCtD
Ezogabine—Feeling abnormal—Budesonide—ulcerative colitis	0.00102	0.00216	CcSEcCtD
Ezogabine—Confusional state—Mesalazine—ulcerative colitis	0.00102	0.00215	CcSEcCtD
Ezogabine—Hallucination—Hydrocortisone—ulcerative colitis	0.00101	0.00212	CcSEcCtD
Ezogabine—Infection—Mesalazine—ulcerative colitis	0.001	0.00212	CcSEcCtD
Ezogabine—Visual impairment—Prednisolone—ulcerative colitis	0.000997	0.0021	CcSEcCtD
Ezogabine—Shock—Mesalazine—ulcerative colitis	0.000993	0.0021	CcSEcCtD
Ezogabine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00099	0.00209	CcSEcCtD
Ezogabine—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000989	0.00209	CcSEcCtD
Ezogabine—Weight increased—Dexamethasone—ulcerative colitis	0.000982	0.00207	CcSEcCtD
Ezogabine—Weight increased—Betamethasone—ulcerative colitis	0.000982	0.00207	CcSEcCtD
Ezogabine—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000976	0.00206	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000957	0.00202	CcSEcCtD
Ezogabine—Hallucination—Methylprednisolone—ulcerative colitis	0.000945	0.00199	CcSEcCtD
Ezogabine—Eye disorder—Hydrocortisone—ulcerative colitis	0.000944	0.00199	CcSEcCtD
Ezogabine—Visual impairment—Methylprednisolone—ulcerative colitis	0.000915	0.00193	CcSEcCtD
Ezogabine—Feeling abnormal—Azathioprine—ulcerative colitis	0.000913	0.00193	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—SLC39A11—ulcerative colitis	0.000911	0.0253	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC39A11—ulcerative colitis	0.000911	0.0253	CbGpPWpGaD
Ezogabine—Paraesthesia—Mesalazine—ulcerative colitis	0.000907	0.00191	CcSEcCtD
Ezogabine—Dyspnoea—Mesalazine—ulcerative colitis	0.0009	0.0019	CcSEcCtD
Ezogabine—Somnolence—Mesalazine—ulcerative colitis	0.000898	0.00189	CcSEcCtD
Ezogabine—Asthenia—Budesonide—ulcerative colitis	0.000891	0.00188	CcSEcCtD
Ezogabine—Dyspepsia—Mesalazine—ulcerative colitis	0.000889	0.00188	CcSEcCtD
Ezogabine—Eye disorder—Methylprednisolone—ulcerative colitis	0.000887	0.00187	CcSEcCtD
Ezogabine—Mental disorder—Hydrocortisone—ulcerative colitis	0.000885	0.00187	CcSEcCtD
Ezogabine—Malnutrition—Hydrocortisone—ulcerative colitis	0.00088	0.00186	CcSEcCtD
Ezogabine—Neutropenia—Prednisone—ulcerative colitis	0.000878	0.00185	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000872	0.00184	CcSEcCtD
Ezogabine—Fatigue—Mesalazine—ulcerative colitis	0.00087	0.00184	CcSEcCtD
Ezogabine—Constipation—Mesalazine—ulcerative colitis	0.000863	0.00182	CcSEcCtD
Ezogabine—Hallucination—Betamethasone—ulcerative colitis	0.000859	0.00181	CcSEcCtD
Ezogabine—Hallucination—Dexamethasone—ulcerative colitis	0.000859	0.00181	CcSEcCtD
Ezogabine—UGT1A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000856	0.0237	CbGpPWpGaD
Ezogabine—Weight increased—Prednisone—ulcerative colitis	0.000855	0.0018	CcSEcCtD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.00085	0.0236	CbGpPWpGaD
Ezogabine—Vision blurred—Prednisolone—ulcerative colitis	0.000849	0.00179	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000836	0.00176	CcSEcCtD
Ezogabine—Visual impairment—Betamethasone—ulcerative colitis	0.000832	0.00176	CcSEcCtD
Ezogabine—Visual impairment—Dexamethasone—ulcerative colitis	0.000832	0.00176	CcSEcCtD
Ezogabine—Feeling abnormal—Mesalazine—ulcerative colitis	0.000832	0.00176	CcSEcCtD
Ezogabine—Mental disorder—Methylprednisolone—ulcerative colitis	0.000832	0.00176	CcSEcCtD
Ezogabine—Malnutrition—Methylprednisolone—ulcerative colitis	0.000826	0.00174	CcSEcCtD
Ezogabine—Dizziness—Budesonide—ulcerative colitis	0.000821	0.00173	CcSEcCtD
Ezogabine—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000816	0.00172	CcSEcCtD
Ezogabine—Malaise—Prednisolone—ulcerative colitis	0.000812	0.00171	CcSEcCtD
Ezogabine—Vertigo—Prednisolone—ulcerative colitis	0.000809	0.00171	CcSEcCtD
Ezogabine—Syncope—Prednisolone—ulcerative colitis	0.000808	0.0017	CcSEcCtD
Ezogabine—Eye disorder—Betamethasone—ulcerative colitis	0.000807	0.0017	CcSEcCtD
Ezogabine—Eye disorder—Dexamethasone—ulcerative colitis	0.000807	0.0017	CcSEcCtD
Ezogabine—Malaise—Hydrocortisone—ulcerative colitis	0.000793	0.00167	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisolone—ulcerative colitis	0.000792	0.00167	CcSEcCtD
Ezogabine—Vertigo—Hydrocortisone—ulcerative colitis	0.00079	0.00167	CcSEcCtD
Ezogabine—Syncope—Hydrocortisone—ulcerative colitis	0.000789	0.00166	CcSEcCtD
Ezogabine—Rash—Budesonide—ulcerative colitis	0.000783	0.00165	CcSEcCtD
Ezogabine—Dermatitis—Budesonide—ulcerative colitis	0.000782	0.00165	CcSEcCtD
Ezogabine—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000773	0.00163	CcSEcCtD
Ezogabine—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000769	0.00162	CcSEcCtD
Ezogabine—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000767	0.00162	CcSEcCtD
Ezogabine—Alopecia—Dexamethasone—ulcerative colitis	0.000763	0.00161	CcSEcCtD
Ezogabine—Alopecia—Betamethasone—ulcerative colitis	0.000763	0.00161	CcSEcCtD
Ezogabine—Discomfort—Prednisolone—ulcerative colitis	0.000758	0.0016	CcSEcCtD
Ezogabine—Hallucination—Prednisone—ulcerative colitis	0.000748	0.00158	CcSEcCtD
Ezogabine—Malaise—Triamcinolone—ulcerative colitis	0.000747	0.00158	CcSEcCtD
Ezogabine—Anxiety—Hydrocortisone—ulcerative colitis	0.000746	0.00158	CcSEcCtD
Ezogabine—Malaise—Methylprednisolone—ulcerative colitis	0.000745	0.00157	CcSEcCtD
Ezogabine—Vertigo—Triamcinolone—ulcerative colitis	0.000744	0.00157	CcSEcCtD
Ezogabine—Syncope—Triamcinolone—ulcerative colitis	0.000743	0.00157	CcSEcCtD
Ezogabine—Vertigo—Methylprednisolone—ulcerative colitis	0.000743	0.00157	CcSEcCtD
Ezogabine—Syncope—Methylprednisolone—ulcerative colitis	0.000741	0.00156	CcSEcCtD
Ezogabine—Discomfort—Hydrocortisone—ulcerative colitis	0.00074	0.00156	CcSEcCtD
Ezogabine—Nausea—Budesonide—ulcerative colitis	0.000737	0.00156	CcSEcCtD
Ezogabine—Dizziness—Azathioprine—ulcerative colitis	0.000733	0.00155	CcSEcCtD
Ezogabine—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000728	0.00154	CcSEcCtD
Ezogabine—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000726	0.00153	CcSEcCtD
Ezogabine—Asthenia—Mesalazine—ulcerative colitis	0.000724	0.00153	CcSEcCtD
Ezogabine—Shock—Prednisolone—ulcerative colitis	0.000723	0.00153	CcSEcCtD
Ezogabine—Infection—Hydrocortisone—ulcerative colitis	0.000713	0.00151	CcSEcCtD
Ezogabine—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000711	0.0197	CbGpPWpGaD
Ezogabine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000711	0.0015	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000706	0.0196	CbGpPWpGaD
Ezogabine—Shock—Hydrocortisone—ulcerative colitis	0.000706	0.00149	CcSEcCtD
Ezogabine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000704	0.00149	CcSEcCtD
Ezogabine—Eye disorder—Prednisone—ulcerative colitis	0.000703	0.00148	CcSEcCtD
Ezogabine—CYP2A6—NRF2 pathway—SLC39A11—ulcerative colitis	0.000703	0.0195	CbGpPWpGaD
Ezogabine—Anxiety—Methylprednisolone—ulcerative colitis	0.000701	0.00148	CcSEcCtD
Ezogabine—Rash—Azathioprine—ulcerative colitis	0.000699	0.00147	CcSEcCtD
Ezogabine—Dermatitis—Azathioprine—ulcerative colitis	0.000698	0.00147	CcSEcCtD
Ezogabine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000697	0.00147	CcSEcCtD
Ezogabine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000697	0.00147	CcSEcCtD
Ezogabine—Discomfort—Triamcinolone—ulcerative colitis	0.000697	0.00147	CcSEcCtD
Ezogabine—Discomfort—Methylprednisolone—ulcerative colitis	0.000695	0.00147	CcSEcCtD
Ezogabine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000694	0.00146	CcSEcCtD
Ezogabine—Dry mouth—Triamcinolone—ulcerative colitis	0.00069	0.00146	CcSEcCtD
Ezogabine—Confusional state—Methylprednisolone—ulcerative colitis	0.00068	0.00144	CcSEcCtD
Ezogabine—Malaise—Betamethasone—ulcerative colitis	0.000678	0.00143	CcSEcCtD
Ezogabine—Malaise—Dexamethasone—ulcerative colitis	0.000678	0.00143	CcSEcCtD
Ezogabine—Vertigo—Dexamethasone—ulcerative colitis	0.000675	0.00143	CcSEcCtD
Ezogabine—Vertigo—Betamethasone—ulcerative colitis	0.000675	0.00143	CcSEcCtD
Ezogabine—Syncope—Betamethasone—ulcerative colitis	0.000674	0.00142	CcSEcCtD
Ezogabine—Syncope—Dexamethasone—ulcerative colitis	0.000674	0.00142	CcSEcCtD
Ezogabine—Infection—Triamcinolone—ulcerative colitis	0.000672	0.00142	CcSEcCtD
Ezogabine—Infection—Methylprednisolone—ulcerative colitis	0.00067	0.00141	CcSEcCtD
Ezogabine—Dizziness—Mesalazine—ulcerative colitis	0.000668	0.00141	CcSEcCtD
Ezogabine—Shock—Triamcinolone—ulcerative colitis	0.000665	0.0014	CcSEcCtD
Ezogabine—Alopecia—Prednisone—ulcerative colitis	0.000664	0.0014	CcSEcCtD
Ezogabine—Shock—Methylprednisolone—ulcerative colitis	0.000664	0.0014	CcSEcCtD
Ezogabine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000661	0.0014	CcSEcCtD
Ezogabine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000661	0.00139	CcSEcCtD
Ezogabine—Loss of consciousness—Betamethasone—ulcerative colitis	0.000661	0.00139	CcSEcCtD
Ezogabine—Paraesthesia—Prednisolone—ulcerative colitis	0.00066	0.00139	CcSEcCtD
Ezogabine—Mental disorder—Prednisone—ulcerative colitis	0.000659	0.00139	CcSEcCtD
Ezogabine—Nausea—Azathioprine—ulcerative colitis	0.000658	0.00139	CcSEcCtD
Ezogabine—Malnutrition—Prednisone—ulcerative colitis	0.000655	0.00138	CcSEcCtD
Ezogabine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000654	0.00138	CcSEcCtD
Ezogabine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000652	0.00138	CcSEcCtD
Ezogabine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000645	0.00136	CcSEcCtD
Ezogabine—Anxiety—Dexamethasone—ulcerative colitis	0.000638	0.00135	CcSEcCtD
Ezogabine—Anxiety—Betamethasone—ulcerative colitis	0.000638	0.00135	CcSEcCtD
Ezogabine—Rash—Mesalazine—ulcerative colitis	0.000637	0.00134	CcSEcCtD
Ezogabine—Dermatitis—Mesalazine—ulcerative colitis	0.000636	0.00134	CcSEcCtD
Ezogabine—Discomfort—Betamethasone—ulcerative colitis	0.000632	0.00133	CcSEcCtD
Ezogabine—Discomfort—Dexamethasone—ulcerative colitis	0.000632	0.00133	CcSEcCtD
Ezogabine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000632	0.00133	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00062	0.00131	CcSEcCtD
Ezogabine—Fatigue—Hydrocortisone—ulcerative colitis	0.000619	0.00131	CcSEcCtD
Ezogabine—Vision blurred—Prednisone—ulcerative colitis	0.000617	0.0013	CcSEcCtD
Ezogabine—KCNQ2—Axon guidance—ARPC2—ulcerative colitis	0.000616	0.0171	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—ARPC2—ulcerative colitis	0.000616	0.0171	CbGpPWpGaD
Ezogabine—Infection—Betamethasone—ulcerative colitis	0.000609	0.00129	CcSEcCtD
Ezogabine—Infection—Dexamethasone—ulcerative colitis	0.000609	0.00129	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisone—ulcerative colitis	0.000607	0.00128	CcSEcCtD
Ezogabine—Paraesthesia—Triamcinolone—ulcerative colitis	0.000607	0.00128	CcSEcCtD
Ezogabine—Feeling abnormal—Prednisolone—ulcerative colitis	0.000606	0.00128	CcSEcCtD
Ezogabine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000606	0.00128	CcSEcCtD
Ezogabine—Shock—Betamethasone—ulcerative colitis	0.000603	0.00127	CcSEcCtD
Ezogabine—Shock—Dexamethasone—ulcerative colitis	0.000603	0.00127	CcSEcCtD
Ezogabine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000603	0.00127	CcSEcCtD
Ezogabine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000602	0.00127	CcSEcCtD
Ezogabine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000602	0.00127	CcSEcCtD
Ezogabine—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000601	0.00127	CcSEcCtD
Ezogabine—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000601	0.00127	CcSEcCtD
Ezogabine—Nausea—Mesalazine—ulcerative colitis	0.0006	0.00127	CcSEcCtD
Ezogabine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000595	0.00126	CcSEcCtD
Ezogabine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000594	0.00125	CcSEcCtD
Ezogabine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000593	0.00125	CcSEcCtD
Ezogabine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000593	0.00125	CcSEcCtD
Ezogabine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000592	0.00125	CcSEcCtD
Ezogabine—Malaise—Prednisone—ulcerative colitis	0.00059	0.00125	CcSEcCtD
Ezogabine—Vertigo—Prednisone—ulcerative colitis	0.000588	0.00124	CcSEcCtD
Ezogabine—Syncope—Prednisone—ulcerative colitis	0.000587	0.00124	CcSEcCtD
Ezogabine—Fatigue—Triamcinolone—ulcerative colitis	0.000583	0.00123	CcSEcCtD
Ezogabine—Fatigue—Methylprednisolone—ulcerative colitis	0.000582	0.00123	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisone—ulcerative colitis	0.000575	0.00121	CcSEcCtD
Ezogabine—KCNQ5—Neuronal System—CALM3—ulcerative colitis	0.000559	0.0155	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—CALM3—ulcerative colitis	0.000559	0.0155	CbGpPWpGaD
Ezogabine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000557	0.00118	CcSEcCtD
Ezogabine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000556	0.00117	CcSEcCtD
Ezogabine—Anxiety—Prednisone—ulcerative colitis	0.000555	0.00117	CcSEcCtD
Ezogabine—Paraesthesia—Betamethasone—ulcerative colitis	0.000551	0.00116	CcSEcCtD
Ezogabine—Paraesthesia—Dexamethasone—ulcerative colitis	0.000551	0.00116	CcSEcCtD
Ezogabine—Discomfort—Prednisone—ulcerative colitis	0.000551	0.00116	CcSEcCtD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	0.000544	0.0151	CbGpPWpGaD
Ezogabine—Dyspepsia—Betamethasone—ulcerative colitis	0.00054	0.00114	CcSEcCtD
Ezogabine—Dyspepsia—Dexamethasone—ulcerative colitis	0.00054	0.00114	CcSEcCtD
Ezogabine—Infection—Prednisone—ulcerative colitis	0.000531	0.00112	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00053	0.00112	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00053	0.00112	CcSEcCtD
Ezogabine—Fatigue—Dexamethasone—ulcerative colitis	0.000529	0.00112	CcSEcCtD
Ezogabine—Fatigue—Betamethasone—ulcerative colitis	0.000529	0.00112	CcSEcCtD
Ezogabine—Shock—Prednisone—ulcerative colitis	0.000526	0.00111	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—PTGS1—ulcerative colitis	0.000525	0.0146	CbGpPWpGaD
Ezogabine—Nervous system disorder—Prednisone—ulcerative colitis	0.000524	0.00111	CcSEcCtD
Ezogabine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000516	0.00109	CcSEcCtD
Ezogabine—Asthenia—Hydrocortisone—ulcerative colitis	0.000515	0.00109	CcSEcCtD
Ezogabine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000505	0.00107	CcSEcCtD
Ezogabine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000505	0.00107	CcSEcCtD
Ezogabine—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000491	0.0136	CbGpPWpGaD
Ezogabine—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000491	0.0136	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000488	0.0135	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000488	0.0135	CbGpPWpGaD
Ezogabine—Dizziness—Prednisolone—ulcerative colitis	0.000486	0.00103	CcSEcCtD
Ezogabine—Asthenia—Triamcinolone—ulcerative colitis	0.000485	0.00102	CcSEcCtD
Ezogabine—Asthenia—Methylprednisolone—ulcerative colitis	0.000484	0.00102	CcSEcCtD
Ezogabine—Paraesthesia—Prednisone—ulcerative colitis	0.00048	0.00101	CcSEcCtD
Ezogabine—Dizziness—Hydrocortisone—ulcerative colitis	0.000475	0.001	CcSEcCtD
Ezogabine—Dyspepsia—Prednisone—ulcerative colitis	0.00047	0.000992	CcSEcCtD
Ezogabine—Rash—Prednisolone—ulcerative colitis	0.000463	0.000978	CcSEcCtD
Ezogabine—Dermatitis—Prednisolone—ulcerative colitis	0.000463	0.000977	CcSEcCtD
Ezogabine—Fatigue—Prednisone—ulcerative colitis	0.000461	0.000972	CcSEcCtD
Ezogabine—Constipation—Prednisone—ulcerative colitis	0.000457	0.000964	CcSEcCtD
Ezogabine—Rash—Hydrocortisone—ulcerative colitis	0.000453	0.000955	CcSEcCtD
Ezogabine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000452	0.000954	CcSEcCtD
Ezogabine—Dizziness—Triamcinolone—ulcerative colitis	0.000447	0.000943	CcSEcCtD
Ezogabine—Dizziness—Methylprednisolone—ulcerative colitis	0.000446	0.000941	CcSEcCtD
Ezogabine—KCNQ2—Axon guidance—LAMB1—ulcerative colitis	0.000441	0.0122	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—LAMB1—ulcerative colitis	0.000441	0.0122	CbGpPWpGaD
Ezogabine—Feeling abnormal—Prednisone—ulcerative colitis	0.00044	0.000929	CcSEcCtD
Ezogabine—Asthenia—Dexamethasone—ulcerative colitis	0.00044	0.000929	CcSEcCtD
Ezogabine—Asthenia—Betamethasone—ulcerative colitis	0.00044	0.000929	CcSEcCtD
Ezogabine—KCNQ3—Developmental Biology—ARPC2—ulcerative colitis	0.000439	0.0122	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ARPC2—ulcerative colitis	0.000439	0.0122	CbGpPWpGaD
Ezogabine—Nausea—Prednisolone—ulcerative colitis	0.000437	0.000921	CcSEcCtD
Ezogabine—KCNQ2—Developmental Biology—NR5A2—ulcerative colitis	0.000426	0.0118	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NR5A2—ulcerative colitis	0.000426	0.0118	CbGpPWpGaD
Ezogabine—Nausea—Hydrocortisone—ulcerative colitis	0.000426	0.0009	CcSEcCtD
Ezogabine—Rash—Triamcinolone—ulcerative colitis	0.000426	0.0009	CcSEcCtD
Ezogabine—Dermatitis—Triamcinolone—ulcerative colitis	0.000426	0.000899	CcSEcCtD
Ezogabine—Rash—Methylprednisolone—ulcerative colitis	0.000425	0.000898	CcSEcCtD
Ezogabine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000425	0.000897	CcSEcCtD
Ezogabine—KCNQ4—Neuronal System—ADCY5—ulcerative colitis	0.000406	0.0112	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—ADCY5—ulcerative colitis	0.000406	0.0112	CbGpPWpGaD
Ezogabine—Dizziness—Betamethasone—ulcerative colitis	0.000406	0.000856	CcSEcCtD
Ezogabine—Dizziness—Dexamethasone—ulcerative colitis	0.000406	0.000856	CcSEcCtD
Ezogabine—Nausea—Triamcinolone—ulcerative colitis	0.000402	0.000847	CcSEcCtD
Ezogabine—Nausea—Methylprednisolone—ulcerative colitis	0.000401	0.000846	CcSEcCtD
Ezogabine—Rash—Dexamethasone—ulcerative colitis	0.000387	0.000816	CcSEcCtD
Ezogabine—Rash—Betamethasone—ulcerative colitis	0.000387	0.000816	CcSEcCtD
Ezogabine—Dermatitis—Dexamethasone—ulcerative colitis	0.000386	0.000815	CcSEcCtD
Ezogabine—Dermatitis—Betamethasone—ulcerative colitis	0.000386	0.000815	CcSEcCtD
Ezogabine—Asthenia—Prednisone—ulcerative colitis	0.000383	0.000809	CcSEcCtD
Ezogabine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000379	0.0105	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000365	0.0101	CbGpPWpGaD
Ezogabine—Nausea—Dexamethasone—ulcerative colitis	0.000364	0.000769	CcSEcCtD
Ezogabine—Nausea—Betamethasone—ulcerative colitis	0.000364	0.000769	CcSEcCtD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—ulcerative colitis	0.000361	0.01	CbGpPWpGaD
Ezogabine—Dizziness—Prednisone—ulcerative colitis	0.000353	0.000745	CcSEcCtD
Ezogabine—Rash—Prednisone—ulcerative colitis	0.000337	0.000711	CcSEcCtD
Ezogabine—Dermatitis—Prednisone—ulcerative colitis	0.000336	0.00071	CcSEcCtD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000326	0.00904	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000325	0.009	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—PTGS1—ulcerative colitis	0.000318	0.00883	CbGpPWpGaD
Ezogabine—Nausea—Prednisone—ulcerative colitis	0.000317	0.00067	CcSEcCtD
Ezogabine—KCNQ3—Developmental Biology—LAMB1—ulcerative colitis	0.000314	0.00872	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—LAMB1—ulcerative colitis	0.000314	0.00872	CbGpPWpGaD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	0.000313	0.00869	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000304	0.00842	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—CALM3—ulcerative colitis	0.000302	0.00837	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—CALM3—ulcerative colitis	0.000302	0.00837	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TCF4—ulcerative colitis	0.000275	0.00762	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TCF4—ulcerative colitis	0.000275	0.00762	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000271	0.00751	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.00027	0.00748	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000265	0.00736	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—PTGS1—ulcerative colitis	0.000265	0.00734	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000253	0.00702	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HNF4A—ulcerative colitis	0.000238	0.00661	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HNF4A—ulcerative colitis	0.000238	0.00661	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000236	0.00656	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—ADCY5—ulcerative colitis	0.000219	0.00607	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—ADCY5—ulcerative colitis	0.000219	0.00607	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CHP1—ulcerative colitis	0.000215	0.00597	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000211	0.00584	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.00021	0.00582	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.00021	0.00582	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000197	0.00545	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000187	0.00519	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000187	0.00519	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000186	0.00517	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000186	0.00517	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—DLD—ulcerative colitis	0.000186	0.00515	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—PTGS1—ulcerative colitis	0.000183	0.00507	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	0.000183	0.00507	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000145	0.00403	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000145	0.00403	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—PTGS1—ulcerative colitis	0.000141	0.00391	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000136	0.00377	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000136	0.00377	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CHP1—ulcerative colitis	0.00013	0.00362	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	0.000127	0.00353	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	0.000125	0.00346	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—JAK2—ulcerative colitis	0.000121	0.00336	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—JAK2—ulcerative colitis	0.000121	0.00336	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—ulcerative colitis	0.00012	0.00334	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—DLD—ulcerative colitis	0.000113	0.00312	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CHP1—ulcerative colitis	0.000108	0.00301	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—PPARG—ulcerative colitis	0.000103	0.00287	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—PPARG—ulcerative colitis	0.000103	0.00287	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—TGFB1—ulcerative colitis	0.000101	0.00279	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MMP9—ulcerative colitis	0.0001	0.00277	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MMP9—ulcerative colitis	0.0001	0.00277	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—DLD—ulcerative colitis	9.36e-05	0.0026	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS1—ulcerative colitis	8.98e-05	0.00249	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—JAK2—ulcerative colitis	8.65e-05	0.0024	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—JAK2—ulcerative colitis	8.65e-05	0.0024	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	8.59e-05	0.00238	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—RELA—ulcerative colitis	8.38e-05	0.00232	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—RELA—ulcerative colitis	8.38e-05	0.00232	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—TGFB1—ulcerative colitis	8.36e-05	0.00232	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CALM3—ulcerative colitis	8.09e-05	0.00224	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CHP1—ulcerative colitis	7.49e-05	0.00208	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CHP1—ulcerative colitis	7.49e-05	0.00208	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP9—ulcerative colitis	7.14e-05	0.00198	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP9—ulcerative colitis	7.14e-05	0.00198	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NFKB1—ulcerative colitis	7.06e-05	0.00196	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NFKB1—ulcerative colitis	7.06e-05	0.00196	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.02e-05	0.00195	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—DLD—ulcerative colitis	6.47e-05	0.00179	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—DLD—ulcerative colitis	6.47e-05	0.00179	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—STAT3—ulcerative colitis	6.35e-05	0.00176	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—STAT3—ulcerative colitis	6.35e-05	0.00176	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCB1—ulcerative colitis	6.29e-05	0.00174	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—ulcerative colitis	6.21e-05	0.00172	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—ulcerative colitis	6.21e-05	0.00172	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TGFB1—ulcerative colitis	5.88e-05	0.00163	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TGFB1—ulcerative colitis	5.88e-05	0.00163	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADCY5—ulcerative colitis	5.87e-05	0.00163	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CHP1—ulcerative colitis	5.77e-05	0.0016	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFB1—ulcerative colitis	5.77e-05	0.0016	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	5.77e-05	0.0016	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—ulcerative colitis	5.49e-05	0.00152	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—ulcerative colitis	5.49e-05	0.00152	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS1—ulcerative colitis	5.44e-05	0.00151	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—DLD—ulcerative colitis	4.98e-05	0.00138	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CALM3—ulcerative colitis	4.9e-05	0.00136	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS1—ulcerative colitis	4.52e-05	0.00125	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TGFB1—ulcerative colitis	4.45e-05	0.00123	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—ulcerative colitis	4.43e-05	0.00123	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—ulcerative colitis	4.43e-05	0.00123	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—ulcerative colitis	4.38e-05	0.00121	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CALM3—ulcerative colitis	4.07e-05	0.00113	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—ulcerative colitis	3.94e-05	0.00109	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—ulcerative colitis	3.81e-05	0.00106	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADCY5—ulcerative colitis	3.56e-05	0.000986	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—ulcerative colitis	3.44e-05	0.000955	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.42e-05	0.000948	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—ulcerative colitis	3.17e-05	0.000878	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS1—ulcerative colitis	3.13e-05	0.000867	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS1—ulcerative colitis	3.13e-05	0.000867	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.07e-05	0.000853	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADCY5—ulcerative colitis	2.96e-05	0.000819	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CALM3—ulcerative colitis	2.81e-05	0.00078	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CALM3—ulcerative colitis	2.81e-05	0.00078	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.69e-05	0.000746	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—ulcerative colitis	2.65e-05	0.000735	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS1—ulcerative colitis	2.41e-05	0.000668	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—ulcerative colitis	2.38e-05	0.000661	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—ulcerative colitis	2.2e-05	0.000611	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—ulcerative colitis	2.19e-05	0.000607	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—ulcerative colitis	2.19e-05	0.000607	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CALM3—ulcerative colitis	2.17e-05	0.000602	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—ulcerative colitis	2.09e-05	0.000578	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADCY5—ulcerative colitis	2.04e-05	0.000566	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADCY5—ulcerative colitis	2.04e-05	0.000566	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—ulcerative colitis	1.98e-05	0.00055	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—ulcerative colitis	1.73e-05	0.000481	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—ulcerative colitis	1.69e-05	0.000468	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADCY5—ulcerative colitis	1.57e-05	0.000436	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—ulcerative colitis	1.52e-05	0.000422	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—ulcerative colitis	1.52e-05	0.000422	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—ulcerative colitis	1.37e-05	0.00038	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—ulcerative colitis	1.37e-05	0.00038	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—ulcerative colitis	1.2e-05	0.000332	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—ulcerative colitis	1.2e-05	0.000332	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—ulcerative colitis	1.17e-05	0.000326	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—ulcerative colitis	1.06e-05	0.000293	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—ulcerative colitis	9.23e-06	0.000256	CbGpPWpGaD
